Sema4 Signal Hereditary Cancer for Research
The Sema4 Signal family also includes Sema4 Signal Hereditary Cancer, the most comprehensive germline oncology panel on the market:
- 112 clinically-relevant genes
- Enables researchers and clinicians to determine if a patient carries inherited genetic changes that increase the risk of cancer or inform on treatment
- Delivered via our TraversaTM Genomic Platform (whole clinical exome, low-pass genome) with biobanking to support future testing
- Integration with Sema4 Signal somatic and informatics solutions creates a holistic approach that can help inform better personalized clinical care decisions
Start your Journey with Us
Please reach out to our team by filling out the form below.